Drug lookup
Drug reference

doxercalciferol

Vitamin D analogue

Vitamin D analogue
CDSCO approved
EXCRETION
not curated
INTERACTIONS
10 major
SEVERE in our sources
PREGNANCY
not curated
Top interactionssee all 10
  • Aluminum HydroxideSevereDatabaseDDInter
  • BurosumabSevereDatabaseDDInter
  • CalcifediolSevereDatabaseDDInter
  • CalcitriolSevereDatabaseDDInter

Mechanism

A prodrug (1α-hydroxyvitamin D2) that must first be activated by hepatic 25-hydroxylation.

Indications

secondary hyperparathyroidism in patients with chronic kidney disease (CKD)

Side effects

Serious
  • hypercalcemia
  • hypercalciuria
  • hyperphosphatemia

Drug interactions

Aluminum Hydroxide
Severe
Database

Clinical effect not specified

Source: DDInter

Burosumab
Severe
Database

Clinical effect not specified

Source: DDInter

Calcifediol
Severe
Database

Clinical effect not specified

Source: DDInter

Calcitriol
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Cholecalciferol
Severe
Database

Clinical effect not specified

Source: DDInter

Dihydrotachysterol
Severe
Database

Clinical effect not specified

Source: DDInter

Erdafitinib
Severe
Database

Clinical effect not specified

Source: DDInter

Ergocalciferol
Severe
Database

Clinical effect not specified

Source: DDInter

Paricalcitol
Severe
Database

Clinical effect not specified

Source: DDInter

Sucralfate
Severe
Database

Clinical effect not specified

Source: DDInter

2 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Vitamin D analogue drugs

Ask House about doxercalciferol

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team